Hippo Signal Transduction Mechanisms in T Cell Immunity
Open Access
- 1 January 2020
- journal article
- review article
- Published by XMLink in Immune Network
- Vol. 20 (5) , e36
Abstract
Bouchard A, et al. Immune Netw. 2020 Oct;20(5):e36. https://doi.org/10.4110/in.2020.20.e36Keywords
Funding Information
- Canadian Institutes of Health Research (PJT 159526)
This publication has 65 references indexed in Scilit:
- The Hippo Pathway as a Driver of Select Human CancersTrends in Cancer, 2020
- MST1/2 Balance Immune Activation and Tolerance by Orchestrating Adhesion, Transcription, and Organelle Dynamics in LymphocytesFrontiers in Immunology, 2020
- Molecular Mechanism of Hippo–YAP1/TAZ Pathway in Heart Development, Disease, and RegenerationFrontiers in Physiology, 2020
- Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and GliomaCellular and Molecular Neurobiology, 2019
- Mechanisms of Hippo pathway regulationGenes & Development, 2016
- The phenotype of human STK4 deficiencyBlood, 2012
- MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survivalBlood, 2012
- Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppressionProceedings of the National Academy of Sciences, 2010
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liverProceedings of the National Academy of Sciences, 2010
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009